Who
William C. Weldon
Director
Company insider
Files Form 4 as: Director, Heartflow; Director, CVS Health; Director, Exxon Mobil; Director, JP Morgan Chase & Co; Director, Chubb; Chairman/CEO, Johnson & Johnson.
In numbers
- Trades disclosed
- 307
- Buys
- 2
- Sells
- 9
- Bought
- $401K
- Sold
- $117.9M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 20 Dec 2005
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $143K17,123 at $8.33 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $143K17,123 at $8.33 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $143K17,123 at $8.33 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —17,123 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —17,123 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —17,123 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —17,123 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —17,123 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code M | —17,123 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $143K17,123 at $8.33 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $143K17,123 at $8.33 | filing |
| 8 Jul 2026filed 10 Jul 2026 | HTFL HeartflowMedical Devices | SEC FORM 4 Code M | $143K17,123 at $8.33 | filing |
| 16 Jun 2026filed 18 Jun 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | $515K16,075 at $32.05 | filing |
| 16 Jun 2026filed 18 Jun 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | $515K16,075 at $32.05 | filing |
| 11 Aug 2025filed 11 Aug 2025 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code C | —83,442 | filing |
| 11 Aug 2025filed 11 Aug 2025 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code C | —25,160 | filing |
| 11 Aug 2025filed 11 Aug 2025 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code C | —27,704 | filing |
| 11 Aug 2025filed 11 Aug 2025 | HTFL HeartflowMedical Devices | SEC FORM 4 Code C | —136,286 | filing |
| 7 Aug 2025filed 11 Aug 2025 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,710 at $0.00 | filing |
| 17 Nov 2022filed 21 Nov 2022 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $168K1,764.46 at $94.93 | filing |
News
Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026JNJ · finanznachrichten.de · 22 Oct 2026Johnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500?JNJ · aol.com · 21 Oct 2026Johnson & Johnson (JNJ) Drugs Lift Guidance, but Is 23 Times Earnings Fair?JNJ · insidermonkey.com · 21 Oct 2026
0 headlines in the last 90 days name William C. Weldon; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.